Cannabinoids have been shown to be great at relieving the symptoms of multiple sclerosis (MS) because they are able to relieve pain and reduce inflammation. This study further showed that on top of these other effects, cannabinoids are also neuroprotective and are able to slow the neurodegeneration that occurs in MS. Using a model of MS in mice, researchers showed that an activation of CB1 receptors was able to slow the neurodegenerative processes in these mice.
